SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-042777
Filing Date
2021-03-29
Accepted
2021-03-29 08:00:32
Documents
9
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm212433d1_pre14a.htm PRE 14A 2266998
2 GRAPHIC tm212433d1_14aimg001.jpg GRAPHIC 10888
3 GRAPHIC tm212433d1_14aimg002.jpg GRAPHIC 28646
4 GRAPHIC tm212433d1_14aimg003.jpg GRAPHIC 35689
5 GRAPHIC tm212433d1_14aimg004.jpg GRAPHIC 107079
6 GRAPHIC tm212433d1_14aimg005.jpg GRAPHIC 77472
7 GRAPHIC tm212433d1_14aimg006.jpg GRAPHIC 8810
8 GRAPHIC tm212433d1_14aimg007.jpg GRAPHIC 4942
9 GRAPHIC tm212433d1_14aimg008.jpg GRAPHIC 7332
  Complete submission text file 0001104659-21-042777.txt   2656259
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37368 | Film No.: 21779509
SIC: 2836 Biological Products, (No Diagnostic Substances)